New hope for Hard-to-Treat cancers? first human trial launches
Disease control
Recruiting now
This early-stage study is testing a new drug called AT03-65 in 83 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the right dose, while also looking for early signs that the drug might shrink tumors. Part…
Phase: PHASE1 • Sponsor: Axcynsis Therapeutics Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC